Loading clinical trials...
Loading clinical trials...
This is an Exploratory Multi-center, Pilot Study to Evaluate the Safety, Efficacy and Ergonomics of Cutera truSculpt Device. Subjects May Receive up to Three Treatments and Will be Followed at 12 Weeks Post the First and Final Treatment.
Conditions
Interventions
truSculpt
Locations
3
United States
Cutera Research Center
Brisbane, California, United States
Skin Associates of South Florida
Coral Gables, Florida, United States
The Dermatology Institute of DuPage Medical Group
Naperville, Illinois, United States
Start Date
August 17, 2017
Primary Completion Date
March 7, 2018
Completion Date
March 7, 2018
Last Updated
September 18, 2023
NCT06886048
NCT06996431
NCT06380920
NCT07425093
NCT01859091
NCT02081209
Lead Sponsor
Cutera Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions